Results 21 to 30 of about 15,538 (160)

Treatment of inflammatory myopathies [PDF]

Postgraduate Medical Journal, 2006
Abstract Idiopathic inflammatory myopathies, notably polymyositis and dermatomyositis are comparatively uncommon diseases and few randomised, double blind placebo controlled trials have been done. Final validation of measures to assess outcome and response to treatment is awaited.
A C, Cordeiro, D A, Isenberg
openaire   +2 more sources

Current essentials in inflammatory myopathies [PDF]

European Medical Journal Neurology, 2013
Inflammatory myopathies are a heterogeneous group of acquired systemic diseases, which include dermatomyositis (DM), polymyositis (PM), necrotising myopathy (NM) and inclusion body myositis (IBM).
Maren Breithaupt, Jens Schmidt
doaj  

Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy

Journal of Cachexia, Sarcopenia and Muscle
Background Finding sensitive clinical outcome measures has become crucial in natural history studies and therapeutic trials of neuromuscular disorders.
Harmen Reyngoudt, Pierre‐Yves Baudin, Ericky Caldas de Almeida Araújo, Damien Bachasson, Jean‐Marc Boisserie, Kubéraka Mariampillai, Mélanie Annoussamy, Yves Allenbach, Jean‐Yves Hogrel, Pierre G. Carlier, Benjamin Marty, Olivier Benveniste   +11 more
doaj   +1 more source

A Childhood Inflammatory Myopathy with Cytochrome Oxidase Deficiency: Which Came First, the Chicken or the Egg?

Journal of Behçet Uz Children's Hospital, 2023
Inflammatory myopathies are autoimmune disorders rarely seen in childhood. Normally high-dose corticosteroid is the current treatment for inflammatory myopathies. For a specific subgroup of patients with inflammatory myopathy with cytochrome oxidase (COX)
Gülden Diniz, Önder Yavaşcan, Ümit Başak Şarkış, Zübeyde Yıldırım, Caner Alparslan, Can Öztürk, Afig Berdeli   +6 more
doaj   +1 more source

Gene Expression Profiles of Inflammatory Myopathies

Pediatric Neurology Briefs, 2002
The simultaneous expression of 10,000 genes was measured, using Affymetrix GeneChip microarrays, in muscle specimens from 45 patients with various myopathies (dystrophy, congenital myopathy, and inflammatory myopathy) examined at Brigham and Women’s ...
J Gordon Millichap
doaj   +1 more source

Polymyositis Presenting With Nontraumatic Rhabdomyolysis and Dysphagia: A Case Report

Journal of Investigative Medicine High Impact Case Reports, 2022
Idiopathic inflammatory myopathies (IIMs) are a rare, heterogeneous group of diseases with a characteristic clinical presentation consisting of muscle inflammation and weakness.
Jonathan Aldrete MD, Christopher J. Peterson MS, James A. Tarbox MD, John S. Pixley MD   +3 more
doaj   +1 more source

Inflammatory myopathies in the elderly [PDF]

Einstein (São Paulo), 2008
Infl ammatory myopathies were analysed according to its differentpresentations, which include dermatomyositis, polymyositis andinclusion body myopathies, especially related to old age.
Edgard Torres dos Reis Neto, Daniel Feldman Pollak   +1 more
doaj  

Registry of idiopathic inflammatory myopathies (REMAS) from nine Brazilian research centers linked to tertiary care and teaching hospitals

Advances in Rheumatology
Objectives Idiopathic inflammatory myopathies (IIMs) are a group of rare chronic inflammatory diseases that affect the muscle, skin, and other organs. There is a severe lack of evidence for current treatment protocols for IIMs.
Fernando Henrique Carlos de Souza, Renata Miossi, Daniel Brito de Araujo, Jean Marcos de Souza, Simone Appenzeller, Luiz Felipe Adsuara de Sousa, Alexandre Moura dos Santos, Lorenza Rosa Silverio da Silva, Marlise Sitima Mendes Simões Faria, Juliana Almeida Vieira, Laurindo Ferreira da Rocha Junior, Luiz Samuel Gomes Machado, Ana Cecília Diniz Oliveira, Juliana Markus, Ana Gabriela da Silva, Flávia Patrícia Sena Teixeira Santos, Samuel Katsuyuki Shinjo   +16 more
doaj   +1 more source

Inclusion body myositis – pathomechanism and lessons from genetics

Open Medicine, 2015
Inclusion body myositis is a rare, late-onset myopathy. Both inflammatory and myodegenerative features play an important role in their pathogenesis.
Murnyák Balázs, Bodoki Levente, Vincze Melinda, Griger Zoltán, Csonka Tamás, Szepesi Rita, Kurucz Andrea, Dankó Katalin, Hortobágyi Tibor   +8 more
doaj   +1 more source

Inflammasomes and idiopathic inflammatory myopathies

Frontiers in Immunology
Idiopathic inflammatory myopathies (IIM) are a group of systemic autoimmune diseases characterized by muscle weakness and elevated serum creatine kinase levels.
Rui Sun, Jiyan Chu, Jiyan Chu, Ping Li
doaj   +1 more source